246P Nanosomal paclitaxel lipid suspension demonstrates better tumor response and safety versus conventional paclitaxel in patients with metastatic breast cancer

246P Nanosomal paclitaxel lipid suspension demonstrates better tumor response and safety versus conventional paclitaxel in patients with metastatic breast cancer

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 33; p. S649
Main Authors: Chiradoni Thungappa, S., Taran, R., Singh, J.K., Shrivastav, S.P., Vithalani, N.K., Mukherjee, K.K., Nagarkar, R., Maksud, T.M., Mehta, A., Srinivasan, K., Vikranth, M., Sonawane, S.R., Ahmad, A., Sheikh, S., Ali, S.M., Paithankar, M., Rajani, A., Bunger, D., Khan, M.A., Ahmad, I.
Format: Journal Article
Language:English
Published: 01-09-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.285